{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:20:54Z","timestamp":1788258054630,"version":"build-2803163510"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Outpatient parenteral antimicrobial therapy (OPAT) is a cost-effective method of administering intravenous antimicrobial therapy. Although OPAT is well established in the UK and US healthcare systems, few centres in Europe perform it. Here we analysed OPAT for the treatment of patients with spinal infections at our institution. In this retrospective study, patients with spinal infection who required intravenous (i.v.) antimicrobial treatment between 2018 and 2021 were analysed. The duration of short-term antimicrobial treatment for skin and soft tissue infections and complex infections requiring long-term antimicrobial treatment, such as spinal bone or joint infections, were analysed. All patients were discharged with a peripherally inserted central catheter (PICC) line. Prior to discharge, all patients received training in the safe administration of their medications via the PICC line. The duration of OPAT and the rate of readmission after OPAT were analysed. For this study a total of 52 patients who were treated via OPAT due to spinal infections were analyzed. In 35 cases (69.2%) complex spinal infection was reason for i.v. antimicrobial therapy. Surgery was required in 23 of these 35 patients (65.7%). The average hospital stay for these patients was 12\u2009\u00b1\u20096\u00a0days. The remaining 17 patients were treated for an infection of the soft tissue or the skin and hospital stay for these patients was on average 8\u2009\u00b1\u20094\u00a0days. Gram-positive organisms were isolated in 64.4%. <jats:italic>Staphylococcus aureus<\/jats:italic> followed by other <jats:italic>Staphylococcus species<\/jats:italic>, was the most common detected organism. After discharging i.v. antimicrobial treatment was given for an average of 20\u2009\u00b1\u200914\u00a0days. The duration of antimicrobial treatment for soft tissue was 10.8\u2009\u00b1\u20098\u00a0days, and for complex infections 25.1\u2009\u00b1\u200918\u00a0days. The mean follow-up was 21\u2009\u00b1\u200914\u00a0months. There was one case of readmission due to treatment failure. There were no difficulties encountered in implementing OPAT. OPAT is a feasible and effective option for delivering intravenous antimicrobial therapy to patients with spinal infections who can be managed without hospitalisation. OPAT offers patient-centred treatment at home while avoiding the risks associated with hospitalisation, with high levels of patient satisfaction.\n<\/jats:p>","DOI":"10.1038\/s41598-023-33502-7","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:02:19Z","timestamp":1682528539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety and feasibility of outpatient parenteral antimicrobial therapy for patients with spinal infection"],"prefix":"10.1038","volume":"13","author":[{"given":"Fatma","family":"Kilinc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Setzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedjan","family":"Behmanesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Gessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fee","family":"Keil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkhard A. J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Czabanka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Prinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"key":"33502_CR1","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5694\/j.1326-5377.1995.tb139878.x","volume":"162","author":"ML Grayson","year":"1995","unstructured":"Grayson, M. L., Silvers, J. & Turnidge, J. Home intravenous antibiotic therapy: A safe and effective alternative to inpatient care. Med. J. Aust. 162, 249\u2013253 (1995).","journal-title":"Med. J. Aust."},{"key":"33502_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijantimicag.2012.01.016","volume":"39","author":"DA Barr","year":"2012","unstructured":"Barr, D. A., Semple, L. & Seaton, R. A. Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: A retrospective cohort study describing experience and evolution over 10 years. Int. J. Antimicrob. Agents 39, 407\u2013413 (2012).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"33502_CR3","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2165\/00019053-200018050-00004","volume":"18","author":"AO Wai","year":"2000","unstructured":"Wai, A. O., Frighetto, L., Marra, C. A., Chan, E. & Jewesson, P. J. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme: A Canadian teaching hospital and ministry of health perspective. Pharmacoeconomics 18, 451\u2013457 (2000).","journal-title":"Pharmacoeconomics"},{"key":"33502_CR4","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1542\/peds.54.3.358","volume":"54","author":"RW Rucker","year":"1974","unstructured":"Rucker, R. W. & Harrison, G. M. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 54, 358\u2013360 (1974).","journal-title":"Pediatrics"},{"key":"33502_CR5","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/BF01690748","volume":"14","author":"AD Tice","year":"1995","unstructured":"Tice, A. D. Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA. Eur. J. Clin. Microbiol. Infect. Diseases 14, 655\u2013661 (1995).","journal-title":"Eur. J. Clin. Microbiol. Infect. Diseases"},{"key":"33502_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1055\/a-0830-4776","volume":"157","author":"H Baecker","year":"2019","unstructured":"Baecker, H. et al. Outpatient parenteral antibiotic therapy (OPAT) with peripherally inserted central catheter in patients with periprosthetic joint infection. Z. Orthop. Unfall. 157, 510\u2013514 (2019).","journal-title":"Z. Orthop. Unfall."},{"key":"33502_CR7","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/jac\/dkp343","volume":"64","author":"ALN Chapman","year":"2009","unstructured":"Chapman, A. L. N. et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): A UK perspective. J. Antimicrobial. Chemother. 64, 1316\u20131324 (2009).","journal-title":"J. Antimicrobial. Chemother."},{"key":"33502_CR8","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1469-0691.1998.tb00413.x","volume":"4","author":"D Nathwani","year":"1998","unstructured":"Nathwani, D. & Conlon, C. Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: A consensus statement by a working party. Clin. Microbiol. Infect. 4, 537\u2013551 (1998).","journal-title":"Clin. Microbiol. Infect."},{"key":"33502_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s00132-020-03889-6","volume":"50","author":"CK Boese","year":"2021","unstructured":"Boese, C. K. et al. Cost analysis of inpatient versus outpatient intravenous antibiotic treatment for periprosthetic joint infections: A simulation. Orthopade 50, 150\u2013158 (2021).","journal-title":"Orthopade"},{"key":"33502_CR10","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/SMJ.0b013e3181a4eef2","volume":"102","author":"J Larioza","year":"2009","unstructured":"Larioza, J., Heung, L., Girard, A. & Brown, R. B. Management of infective endocarditis in outpatients: Clinical experience with outpatient parenteral antibiotic therapy. South Med. J. 102, 575\u2013579 (2009).","journal-title":"South Med. J."},{"key":"33502_CR11","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jinf.2009.09.009","volume":"59","author":"MR Amodeo","year":"2009","unstructured":"Amodeo, M. R. et al. Outpatient intravenous treatment for infective endocarditis: Safety, effectiveness and one-year outcomes. J. Infect. 59, 387\u2013393 (2009).","journal-title":"J. Infect."},{"key":"33502_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.medmal.2006.01.002","volume":"36","author":"T Galp\u00e9rine","year":"2006","unstructured":"Galp\u00e9rine, T. et al. Antibioth\u00e9rapie parent\u00e9rale ambulatoire (APA), par\u00a0voie intraveineuse dans\u00a0les\u00a0infections ost\u00e9oarticulaires. Med. et Maladies Infect. 36, 132\u2013137. https:\/\/doi.org\/10.1016\/j.medmal.2006.01.002 (2006).","journal-title":"Med. et Maladies Infect."},{"key":"33502_CR13","doi-asserted-by":"publisher","first-page":"iii11","DOI":"10.1093\/jac\/dkq303","volume":"65","author":"T Gouliouris","year":"2010","unstructured":"Gouliouris, T., Aliyu, S. H. & Brown, N. M. Spondylodiscitis: Update on diagnosis and management. J. Antimicrobial. Chemother. 65, iii11\u2013iii24 (2010).","journal-title":"J. Antimicrobial. Chemother."},{"key":"33502_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/00002517-199904000-00001","volume":"12","author":"P Sampath","year":"1999","unstructured":"Sampath, P. & Rigamonti, D. Spinal epidural abscess: A review of epidemiology, diagnosis, and treatment. J. Spinal Disord. 12, 89\u201393 (1999).","journal-title":"J. Spinal Disord."},{"key":"33502_CR15","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3171\/2019.1.SPINE181025","volume":"31","author":"V Prinz","year":"2019","unstructured":"Prinz, V. et al. High frequency of low-virulent microorganisms detected by sonication of pedicle screws: A potential cause for implant failure. J. Neurosurg. Spine 31, 424\u2013429 (2019).","journal-title":"J. Neurosurg. Spine"},{"key":"33502_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00701-018-3467-2","volume":"160","author":"S Lener","year":"2018","unstructured":"Lener, S. et al. Management of spinal infection: A review of the literature. Acta Neurochir. 160, 487\u2013496. https:\/\/doi.org\/10.1007\/s00701-018-3467-2 (2018).","journal-title":"Acta Neurochir."},{"key":"33502_CR17","doi-asserted-by":"publisher","unstructured":"Fleege, C., Rauschmann, M., Arabmotlagh, M. & Rickert, M. Development and current use of local antibiotic carriers in spondylodiscitis: Pilot study on reduction of duration of systemic treatment. Orthopade 49(8), 714\u2013723. https:\/\/doi.org\/10.1007\/s00132-020-03942-4 (2020).","DOI":"10.1007\/s00132-020-03942-4"},{"key":"33502_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-018-3377-1","volume":"18","author":"Y da Li","year":"2018","unstructured":"da Li, Y. et al. Appropriate duration of post-surgical intravenous antibiotic therapy for pyogenic spondylodiscitis. BMC Infect. Dis. 18, 1\u20139 (2018).","journal-title":"BMC Infect. Dis."},{"key":"33502_CR19","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciy745","volume":"68","author":"AH Norris","year":"2019","unstructured":"Norris, A. H. et al. 2018 Infectious Diseases Society of America Clinical practice guideline for the management of outpatient parenteral antimicrobial therapya. Clin. Infect. Dis. 68, e1\u2013e35 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"33502_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jinf.2013.11.011","volume":"68","author":"M Kehrer","year":"2014","unstructured":"Kehrer, M., Pedersen, C., Jensen, T. G. & Lassen, A. T. Increasing incidence of pyogenic spondylodiscitis: A 14-year population-based study. J. Infect. 68, 313\u2013320 (2014).","journal-title":"J. Infect."},{"key":"33502_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.21037\/jss-20-514","volume":"6","author":"V Prinz","year":"2020","unstructured":"Prinz, V. & Vajkoczy, P. Surgical revision strategies for postoperative spinal implant infections (PSII). J. Spine Surg. 6, 777 (2020).","journal-title":"J. Spine Surg."},{"key":"33502_CR22","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3109\/23744235.2015.1103897","volume":"48","author":"T Aagaard","year":"2016","unstructured":"Aagaard, T., Roed, C., Dahl, B. & Obel, N. Long-term prognosis and causes of death after spondylodiscitis: A Danish nationwide cohort study. Infect. Dis. 48, 201\u2013208 (2016).","journal-title":"Infect. Dis."},{"key":"33502_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/qjmed\/hcq178","volume":"104","author":"TW Corrah","year":"2011","unstructured":"Corrah, T. W., Enoch, D. A., Aliyu, S. H. & Lever, A. M. Bacteraemia and subsequent vertebral osteomyelitis: A retrospective review of 125 patients. QJM 104, 201\u2013207 (2011).","journal-title":"QJM"},{"key":"33502_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1056\/NEJMoa1710926","volume":"380","author":"H-K Li","year":"2019","unstructured":"Li, H.-K. et al. Oral versus intravenous antibiotics for bone and joint infection. N. Engl. J. Med. 380, 425\u2013436 (2019).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33502-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33502-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33502-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T17:03:49Z","timestamp":1682528629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-33502-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["33502"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-33502-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"10 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was not supported by any sources and all authors declare no conflict of interest. Any portion of the content of this paper has not been presented elsewhere.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6863"}}